Detailed Analysis of X Chromosome Inactivation in a 49,XXXXX Pentasomy
Overview
Authors
Affiliations
Background: Pentasomy X (49,XXXXX) has been associated with a severe clinical condition, presumably resulting from failure or disruption of X chromosome inactivation. Here we report that some human X chromosomes from a patient with 49,XXXXX pentasomy were functionally active following isolation in inter-specific (human-rodent) cell hybrids. A comparison with cytogenetic and molecular findings provided evidence that more than one active X chromosome was likely to be present in the cells of this patient, accounting for her abnormal phenotype.
Results: 5-bromodeoxyuridine (BrdU)-pulsed cultures showed different patterns among late replicating X chromosomes suggesting that their replication was asynchronic and likely to result in irregular inactivation. Genotyping of the proband and her mother identified four maternal and one paternal X chromosomes in the proband. It also identified the paternal X chromosome haplotype (P), indicating that origin of this X pentasomy resulted from two maternal, meiotic non-disjunctions. Analysis of the HUMANDREC region of the androgen receptor (AR) gene in the patient's mother showed a skewed inactivation pattern, while a similar analysis in the proband showed an active paternal X chromosome and preferentially inactivated X chromosomes carrying the 173 AR allele. Analyses of 33 cell hybrid cell lines selected in medium containing hypoxanthine, aminopterin and thymidine (HAT) allowed for the identification of three maternal X haplotypes (M1, M2 and MR) and showed that X chromosomes with the M1, M2 and P haplotypes were functionally active. In 27 cell hybrids in which more than one X haplotype were detected, analysis of X inactivation patterns provided evidence of preferential inactivation.
Conclusion: Our findings indicated that 12% of X chromosomes with the M1 haplotype, 43.5% of X chromosomes with the M2 haplotype, and 100% of the paternal X chromosome (with the P haplotype) were likely to be functionally active in the proband's cells, a finding indicating that disruption of X inactivation was associated to her severe phenotype.
Shimojima Yamamoto K, Yamamoto S, Imaizumi T, Kumada S, Yamamoto T Hum Genome Var. 2024; 11(1):31.
PMID: 39152134 PMC: 11329761. DOI: 10.1038/s41439-024-00289-6.
Oral manifestation in a pediatric patient with pentasomy x. A case report.
Acosta de Camargo M, Cancado Figueiredo M Rev Cient Odontol (Lima). 2024; 11(1):e147.
PMID: 38303737 PMC: 10832396. DOI: 10.21142/2523-2754-1101-2023-147.
Report of a new case with pentasomy X and novel clinical findings.
Demirhan O, Tanriverdi N, Yilmaz M, Kocaturk-Sel S, Inandiklioglu N, Luleyap U Balkan J Med Genet. 2016; 18(1):85-92.
PMID: 26929910 PMC: 4768830. DOI: 10.1515/bjmg-2015-0010.
A new case of prenatally diagnosed pentasomy x: review of the literature.
Pirollo L, Baghernajad Salehi L, Sarta S, Cassone M, Capogna M, Piccione E Case Rep Obstet Gynecol. 2015; 2015:935202.
PMID: 25699192 PMC: 4325205. DOI: 10.1155/2015/935202.